6-BROMO-2-METHYL-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE, 95.0%, 1g

N,N-Diethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-ethanamine, 95.0%, 1g

4-Isopropyl-3-methylphenol>99.0%(GC)25g

1-(Dimethylethylsilyl)imidazole [Dimethylethylsilylating Agent]>98.0%(T)1g

8-Chloro-6-methylquinoline, 95.0%, 1g

tert-Butyl (4-ethynylphenyl)carbamate, 97%, 2.5g

8-(TRIFLUOROMETHOXY)QUINOLIN-3-OL, 95%, 1g

2-Fluoro-4-phenylnicotinaldehyde, 98%, 500mg

methyl 3-(cyclohexylamino)-2-methylpropanoate, 95.0%, 2g

2-Phenylpent-4-en-2-ol, 98.0%, 5g

5-Isopropoxymethyl-furan-2-carboxylic acid, 95.0%, 500mg

Plan PLPHi S40x/0.65 phase contrast IOS infinity corrected objective

Tert-butyl (S)-2-cyano-4,4-difluoropyrrolidine-1-carboxylate, 98%, 10g